FDA has approved rusfertide, a groundbreaking therapy that promises to spare patients with polycythemia vera (PV) repeated phlebotomies, the agency and officials from Takeda and P ...
China survey reveals what R/R mantle cell lymphoma patients and doctors value after BTK failure—overall survival tops trade-offs despite CRS risk. Despite advances in recent years, treatment choices ...
T-cell therapy has transformed outcomes in several blood cancers, but its success is far from uniform. According to Kerry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results